Watchlist Price Alert

Lantern Pharma Inc. (LTRN)

NASDAQ: LTRN · Real-Time Price · USD

3.83

0.16 (4.36%)

At close: May 06, 2025, 3:59 PM

Lantern Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-20.78M	-15.96M	-14.26M	-12.36M	-5.91M	-2.43M	-1.73M
Depreciation & Amortization	n/a	14.62K	10.08K	6.76K	3.39K	1.63K	-2.54K
Stock-Based Compensation	n/a	1.07M	1.19M	961.54K	1.19M	117.76K	185.6K
Other Working Capital	2.23M	538.02K	-1.03M	-950.47K	-1.06M	-191.79K	271.84K
Other Non-Cash Items	739.85K	-5.17K	906.49K	90.66K	1.08M	-251.65K	-76.32K
Deferred Income Tax	n/a	n/a	n/a	112.56K	-1.08M	251.65K	n/a
Change in Working Capital	2.23M	538.02K	-611.86K	599.96K	-939.06K	180.88K	271.84K
Operating Cash Flow	-17.81M	-14.35M	-12.77M	-10.59M	-5.65M	-2.13M	-1.27M
Capital Expenditures	n/a	-18.73K	-27.84K	-15.5K	-16.14K	-5.72K	n/a
Cash Acquisitions	n/a	n/a	-179.27M	19.53B	n/a	n/a	5.34K
Purchase of Investments	-17.28M	-8.2M	-3.91M	-19.58M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	7.28M	4.12M	64.09K	n/a	n/a	n/a
Other Investing Acitivies	20.65M	-1	179.27M	-19.53B	-5.72M	n/a	5.34K
Investing Cash Flow	3.37M	-930.21K	179.27K	-19.53M	-16.14K	-5.72K	5.34K
Debt Repayment	n/a	n/a	n/a	n/a	108.5K	n/a	n/a
Common Stock Repurchased	n/a	-500K	-2.48M	-939.67K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	66.71K	n/a	n/a	-4.64M	-261	n/a	535K
Financial Cash Flow	66.71K	-500K	-2.18K	63.42M	23.66M	2.92M	535K
Net Cash Flow	-14.43M	-15.81M	-14.78M	33.3M	18M	786.87K	-731.18K
Free Cash Flow	-17.83M	-14.37M	-12.8M	-10.61M	-5.67M	-2.13M	-1.27M